Once U.S. stockpiles of COVID-19 vaccine run out, Moderna says it might charge as much as $130 per dose, but give people who lack health insurance a break. Critics say that's not enough help.
Medicare suddenly stopped paying for the pricey drug that prolongs his life. As he waits for an appeal, this retired physician wonders if he should give up treatment to spare his family the cost.
Drugs to treat multiple sclerosis can run $70,000 a year or more. Patients hoped competition from a generic version of one of the most popular brands would spur relief, but prices went up. Here's why.
Drugmakers hate the idea. But Nancy Pelosi and Donald Trump both say pegging the prices of U.S. medicine to what people elsewhere pay could save U.S. patients a bundle. Here's how an "IPI" might work.
The snakebite antivenin CroFab, on the U.S. market since 2000, now faces competition from a drug called Anavip. But both are expensive. "Perverse incentives" keep prices high, says one legal scholar.
Trump administration officials say drugs' list prices are like cars' sticker prices — easily negotiated. But in the life and death world of medicine, say price watchers, that analogy falls apart.
A pricing tool embedded in many prescribing and medical records systems lets doctors see how much each patient is likely to pay out of pocket for medicine. But the tools could be better, doctors say.
In the 1980s, ACT UP demanded action from the U.S. government and got results with drama. AIDS activists today have fresh tactics for their new goal: a more affordable HIV prevention pill.
The vaccine against Zika vaccine was developed by the Army, with the government paying for clinical trials, too. Health officials want to be sure drugmaker Sanofi Pasteur doesn't make it unaffordable.